A prospective analysis confirms earlier retrospective work showing there is an association between microbiome diversity and survival outcomes in patients with hematologic cancer undergoing allogeneic hematopoietic cell transplantation (HCT).
Previous studies suggested that decreased microbial diversity in the gastrointestinal microbiome, potentially due to chemotherapeutic and antibiotic exposure, may be associated with acute graft-versus-host disease (GVHD) and mortality after allogeneic